Search research articles
Contact Us
Filters
Showing results (71-80 of 125) with videos related to
Page
of 13
Sort By:
Pharmacopsychiatry
|
July 24, 2012
Antipsychotics: a real or confounding risk factor for venous thromboembolism?
C Chapelle, S Quenet, X Delavenne, et al.
Computer Methods in Biomechanics and Biomedical Engineering
|
August 2, 2006
3D reconstruction of the pelvis from bi-planar radiography
D Mitton, S Deschênes, S Laporte, et al.
British Journal of Clinical Pharmacology
|
May 19, 2007
Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old
A Berges, S Laporte, M Epinat, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 6, 2001
Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy
P Girard, M Decousus, S Laporte, et al.
Annales De Chirurgie
|
April 6, 2002
[Laparoscopic re-establishment of digestive continuity following Hartmann's procedure. Retrospective study of the French Society of Endoscopic Surgery]
C Vacher, R Zaghloul, F Borie, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 27, 2006
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer
G Simonneau, S Laporte, P Mismetti, et al.
Thrombosis and Haemostasis
|
February 11, 2000
Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials
P Mismetti, S Laporte-Simitsidis, B Tardy, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
July 13, 2005
[Digestive surgery and varicose vein surgery]
A Steib, S Laporte, B Vailly, et al.
Presse Medicale (Paris, France : 1983)
|
April 26, 2000
[Bepridil: importance of serum level in treatment surveillance]
A Viallon, S Laporte-Simitsidis, V Pouzet, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
Circadian dynamics of coagulation and chronopathology of cardiovascular and cerebrovascular events. Future therapeutic implications for the treatment of these disorders?
H Decousus, C Boissier, B Perpoint, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 125) with videos related to
Sort By:
Page
of 13
Pharmacopsychiatry
|
July 24, 2012
Antipsychotics: a real or confounding risk factor for venous thromboembolism?
C Chapelle, S Quenet, X Delavenne, et al.
Computer Methods in Biomechanics and Biomedical Engineering
|
August 2, 2006
3D reconstruction of the pelvis from bi-planar radiography
D Mitton, S Deschênes, S Laporte, et al.
British Journal of Clinical Pharmacology
|
May 19, 2007
Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old
A Berges, S Laporte, M Epinat, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 6, 2001
Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy
P Girard, M Decousus, S Laporte, et al.
Annales De Chirurgie
|
April 6, 2002
[Laparoscopic re-establishment of digestive continuity following Hartmann's procedure. Retrospective study of the French Society of Endoscopic Surgery]
C Vacher, R Zaghloul, F Borie, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 27, 2006
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer
G Simonneau, S Laporte, P Mismetti, et al.
Thrombosis and Haemostasis
|
February 11, 2000
Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials
P Mismetti, S Laporte-Simitsidis, B Tardy, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
July 13, 2005
[Digestive surgery and varicose vein surgery]
A Steib, S Laporte, B Vailly, et al.
Presse Medicale (Paris, France : 1983)
|
April 26, 2000
[Bepridil: importance of serum level in treatment surveillance]
A Viallon, S Laporte-Simitsidis, V Pouzet, et al.
Annals of the New York Academy of Sciences
|
January 1, 1991
Circadian dynamics of coagulation and chronopathology of cardiovascular and cerebrovascular events. Future therapeutic implications for the treatment of these disorders?
H Decousus, C Boissier, B Perpoint, et al.
Page
of 13